tiprankstipranks
Trending News
More News >
ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market

ADMA Biologics (ADMA) Income Statement

Compare
2,983 Followers

ADMA Biologics Income Statement

Last quarter (Q4 2025), ADMA Biologics's total revenue was $139.16M, an increase of 18.39% from the same quarter last year. In Q4, ADMA Biologics's net income was $49.38M. See ADMA Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 510.17M$ 426.45M$ 258.21M$ 154.08M$ 80.94M
Gross Profit
$ 292.76M$ 219.55M$ 88.94M$ 35.27M$ 1.17M
Operating Expenses
$ 101.32M$ 80.57M$ 67.31M$ 74.63M$ 59.55M
Depreciation and Amortization
$ 8.10M$ 8.04M$ 8.33M$ 7.11M$ 5.50M
EBITDA
$ 197.86M$ 147.69M$ 5.12M$ -39.51M$ -53.09M
Operating Income
$ 191.44M$ 138.98M$ 21.63M$ -39.37M$ -58.37M
Other Income/Expenses
$ -8.79M$ -13.27M$ -49.87M$ -26.54M$ -13.27M
Pretax Income
$ 182.66M$ 125.71M$ -28.24M$ -65.90M$ -71.65M
Net Income
$ 146.93M$ 197.67M$ -28.24M$ -65.90M$ -71.65M
Per Share Metrics
Basic EPS
$ 0.62$ 0.85$ -0.13$ -0.43$ -0.61
Diluted EPS
$ 0.60$ 0.81$ -0.13$ -0.43$ -0.61
Weighted Average Shares Outstanding
238.30M 233.08M 223.98M 197.87M 139.58M
Weighted Average Shares Outstanding (Diluted)
244.90M 243.34M 223.98M 197.87M 139.58M
Currency in USD

ADMA Biologics Earnings and Revenue History